Graf Akcie CBIO (Catalyst Biosciences Inc). Diskuze k akciím CBIO. Aktuální informace CBIO.

Základní informace o společnosti Catalyst Biosciences Inc (Akcie CBIO)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace	125.48M
Hodnota podniku (EV)	66.23M
Tržby	5.523M
EBITDA	-77.12
Zisk	-77.31
Růst v tržbách Q/Q	-31.72 %
Růst v tržbách Y/Y	N/A %
P/E (Cena vůči ziskům)	N/A
Forward P/E	2.12
EV/Sales	11.99
EV/EBITDA	N/A
EV/EBIT	N/A
PEG	0.06
Price/Sales	22.72
P/FCF	N/A
Price/Book	1.65
Účetní hodnota na akcii	2.43
Hotovost na akcii	2.54
FCF vůči ceně	-63.90 %
Počet zaměstnanců	56
Tržba na zaměstnance	98.625k
Profit margin	-268.48 %
Operating margin	-1,399.47 %
Gross margin	56.26 %
EBIT margin	-1,399.71 %
EBITDA margin	-1,396.27 %

EPS - Zisk na akcii	N/A
EPS - Kvartální růst	-33.33 %
EPS - Očekávaný růst příští rok	-9.59 %
Return on assets	-72.33 %
Return on equity	-86.04 %
ROIC	-58.16 %
ROCE	-89.66 %
Dluhy/Equity	0.25
Čistý dluh/EBITDA	4.78
Current ratio	6.22
Quick Ratio	6.22
Volatilita	5.56
Beta	0.86
RSI	42.82
Cílová cena analytiků	19
Známka akcie (dle analytiků)	1.50
Insider ownership	3.33 %
Institutional ownership	72.01 %
Počet akcií	31.366M
Procento shortovaných akcií	2.86 %
Short ratio	4.21 %
Dividenda	0.00
Procentuální dividenda	0.00 %
Dividenda/Zisk	N/A %
Obchodovaná od	2006
Země	United States

Finanční výsledky akcie CBIO

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

#	2020	2019	2018	2017	2016	2015
Revenue	-	$0.006	$1.018	$0.399	$1.75	$1.813
Cost Of Goods Sold	-	-	-	-	-	-
Gross Profit	-	$0.006	$1.018	$0.399	$1.75	$1.813
Research And Development Expenses	$43.859	$21.474	$12.847	$11.555	$5.958	$5.267
SG&A Expenses	$13.418	$12.354	$9.993	$9.262	$9.594	$4.055
Other Operating Income Or Expenses	-	-	-	-	-	-
Operating Expenses	$57.277	$33.828	$22.84	$20.817	$15.552	$9.322
Operating Income	$-57.277	$-33.822	$-21.822	$-20.418	$-13.802	$-7.509
Total Non-Operating Income/Expense	$2.099	$3.767	$0.261	$3.473	$-0.96	$0.896
Pre-Tax Income	$-55.178	$-30.055	$-21.561	$-16.945	$-14.762	$-6.613
Income Taxes	-	-	-	-	-	-
Income After Taxes	$-55.178	$-30.055	$-21.561	$-16.945	$-14.762	$-6.613
Other Income	-	-	-	-	-	-
Income From Continuous Operations	$-55.178	$-30.055	$-21.561	$-16.945	$-14.762	$-6.613
Income From Discontinued Operations	-	-	-	-	-	-
Net Income	$-55.178	$-30.055	$-25.512	$-16.945	$-14.762	$-6.613
EBITDA	$-57.131	$-33.673	$-21.649	$-20.029	$-13.332	$-6.829
EBIT	$-57.277	$-33.822	$-21.822	$-20.418	$-13.802	$-7.509
Basic Shares Outstanding	12	11	3	1	0	0
Shares Outstanding	12	11	3	1	0	0
Basic EPS	$-4.60	$-2.68	$-7.45	$-21.75	$-49.99	$-269.72
EPS - Earnings Per Share	$-4.60	$-2.68	$-7.45	$-21.75	$-49.99	$-269.72

#	2020	2019	2018	2017	2016	2015
Cash On Hand	$76.865	$120.177	$37.776	$36.532	$66.292	$1.594
Receivables	$15	-	-	$0.031	$0.492	$0.095
Inventory	-	-	-	-	-	-
Pre-Paid Expenses	$4.201	$3.814	$1.333	$0.958	$1.781	$0.103
Other Current Assets	-	-	-	-	$0.133	$0.278
Total Current Assets	$96.066	$123.991	$39.109	$37.521	$68.698	$2.07
Property, Plant, And Equipment	$0.304	$0.386	$0.276	$0.444	$0.698	$0.911
Long-Term Investments	-	-	-	-	-	-
Goodwill And Intangible Assets	-	-	-	-	-	-
Other Long-Term Assets	$0.257	$0.543	$0.128	$0.125	$0.125	-
Total Long-Term Assets	$2.488	$0.929	$0.404	$0.569	$0.823	$0.911
Total Assets	$98.554	$124.92	$39.513	$38.09	$69.521	$2.981
Total Current Liabilities	$28.899	$4.801	$8.739	$21.965	$37.756	$2.336
Long Term Debt	-	-	-	-	-	-
Other Non-Current Liabilities	-	-	-	-	-	$0.391
Total Long Term Liabilities	$1.319	$0.174	-	$0.054	$0.34	$1.12
Total Liabilities	$30.218	$4.975	$8.739	$22.019	$38.096	$3.456
Common Stock Net	$0.012	$0.012	$0.006	$0.001	$0.001	-
Retained Earnings (Accumulated Deficit)	$-258.52	$-203.342	$-173.494	$-147.982	$-131.037	$-116.275
Comprehensive Income	$0.034	$-0.004	-	$-0.001	$0.001	-
Other Share Holders Equity	-	-	-	-	-	-
Share Holder Equity	$68.336	$119.945	$30.774	$16.071	$31.425	$-0.475
Total Liabilities And Share Holders Equity	$98.554	$124.92	$39.513	$38.09	$69.521	$2.981

#	2020	2019	2018	2017	2016	2015
Net Income/Loss	$-55.178	$-30.055	$-21.561	$-16.945	$-14.762	$-6.613
Total Depreciation And Amortization - Cash Flow	$0.146	$0.149	$0.173	$0.389	$0.47	$0.68
Other Non-Cash Items	$3.204	$2.722	$0.881	$-2.752	$1.434	$0.021
Total Non-Cash Items	$3.35	$2.871	$1.054	$-2.363	$1.904	$0.701
Change In Accounts Receivable	$-15	-	$0.007	$0.461	$-0.079	$0.001
Change In Inventories	-	-	-	-	-	-
Change In Accounts Payable	$3.031	$0.5	$-0.09	$-0.102	$-4.273	$-0.106
Change In Assets/Liabilities	$14.585	$-2.719	$-0.637	$0.537	$-3.058	$-0.37
Total Change In Assets/Liabilities	$8.215	$-1.369	$0.567	$0.836	$-6.26	$-0.477
Cash Flow From Operating Activities	$-43.613	$-28.553	$-19.94	$-18.472	$-19.118	$-6.389
Net Change In Property, Plant, And Equipment	$-0.064	$-0.376	$-0.023	$2.096	$-0.272	$0.098
Net Change In Intangible Assets	-	-	-	-	-	-
Net Acquisitions/Divestitures	-	-	-	-	-	-
Net Change In Short-term Investments	$-129.977	$-198.912	$-25.472	$-3.399	-	-
Net Change In Long-Term Investments	$157.433	$127.967	$14.3	-	$13.823	-
Net Change In Investments - Total	$27.456	$-70.945	$-11.172	$-3.399	$13.823	-
Investing Activities - Other	-	-	-	$-0.005	$23.806	-
Cash Flow From Investing Activities	$27.392	$-71.321	$-11.195	$-1.308	$37.357	$0.098
Net Long-Term Debt	-	$-5.082	-	$-14.34	$-1.132	-
Net Current Debt	-	-	-	-	-	-
Debt Issuance/Retirement Net - Total	-	$-5.082	-	$-14.34	$-1.132	-
Net Common Equity Issued/Repurchased	$0.327	$116.414	$16.837	$0.958	$-0.069	$0.025
Net Total Equity Issued/Repurchased	$0.327	$116.414	$35.4	$0.958	$7.19	$5.007
Total Common And Preferred Stock Dividends Paid	-	-	-	-	-	-
Financial Activities - Other	-	-	$-14.318	$14.33	$3.255	-
Cash Flow From Financial Activities	$0.327	$111.332	$21.082	$0.948	$9.313	$5.007
Net Cash Flow	$-15.894	$11.458	$-10.053	$-18.832	$27.552	$-1.284
Stock-Based Compensation	$3.204	$2.606	$0.863	$0.635	$0.326	$0.244
Common Stock Dividends Paid	-	-	-	-	-	-

#	2020	2019	2018	2017	2016	2015
Current Ratio	3.3242	25.8261	4.4752	1.7082	1.8195	0.8861
Long-term Debt / Capital	-	-	-	-	-	-
Debt/Equity Ratio	-	-	0.1652	1.2073	1.0738	-
Gross Margin	-	100	100	100	100	100
Operating Margin	-	-563700.1	-2143.615	-5117.293	-788.6857	-414.1755
EBIT Margin	-	-563700.1	-2143.615	-5117.293	-788.6857	-414.1755
EBITDA Margin	-	-561216.8	-2126.621	-5019.8	-761.8286	-376.6686
Pre-Tax Profit Margin	-	-500916.7	-2117.977	-4246.868	-843.5428	-364.7546
Net Profit Margin	-	-500916.7	-2506.09	-4246.867	-843.5428	-364.7545
Asset Turnover	-	-	0.0258	0.0105	0.0252	0.6082
Inventory Turnover Ratio	-	-	-	-	-	-
Receiveable Turnover	-	-	-	12.871	3.5569	19.0842
Days Sales In Receivables	-	-	-	28.3584	102.6171	19.1258
ROE - Return On Equity	-80.7451	-25.0573	-70.0624	-105.4383	-46.9753	6.0474
Return On Tangible Equity	-80.7451	-25.0573	-70.0624	-105.4384	-46.9753	1392.21
ROA - Return On Assets	-55.9876	-24.0594	-54.5669	-44.4868	-21.2339	-221.8383
ROI - Return On Investment	-80.7451	-25.0573	-70.0624	-105.4384	-46.9753	1392.211
Book Value Per Share	5.6753	10.033	5.0607	20.0387	41.2402	-19.1953
Operating Cash Flow Per Share	-1.087	3.2774	17.8889	41.0943	195.4842	-2.5842
Free Cash Flow Per Share	-1.0588	3.2506	15.1915	44.707	190.5697	3.0924

Warning: Undefined array key "user" in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php on line 716

Fatal error: Uncaught mysqli_sql_exception: You have an error in your SQL syntax; check the manual that corresponds to your MariaDB server version for the right syntax to use near 'AND valid >= CURDATE()' at line 2 in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php:11 Stack trace: #0 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php(11): mysqli_query(Object(mysqli), 'SELECT * FROM p...') #1 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/views/stock.php(716): Database::Execute(Object(mysqli), 'SELECT * FROM p...') #2 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(20): require_once('/data/web/virtu...') #3 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): {closure}() #4 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Route.php(8): Closure->__invoke() #5 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/routes.php(21): Route::set('graf-akcie/CBIO', Object(Closure)) #6 /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/index.php(23): require_once('/data/web/virtu...') #7 {main} thrown in /data/web/virtuals/284739/virtual/www/domains/jenakcie.cz/php/classes/Database.php on line 11

JenAkcie

Graf Akcie CBIO (Catalyst Biosciences Inc). Diskuze k akciím CBIO. Aktuální informace CBIO.

Základní informace o společnosti Catalyst Biosciences Inc (Akcie CBIO)

Finanční výsledky akcie CBIO